abstract |
The present invention relates to a disorder characterized by increased or dysregulated myostatin, a disorder capable of improving tissue function utilizing the interaction between follistatin and angiogenin, a neurological disease or disorder, spinal cord injury or disease, bone A method for treating diseases, disorders, diseases involving glucose homeostasis, wound healing, neuroprotection, assisting nervous system function or managing metabolic diseases, comprising an effective amount of angiogenin or angiogenin agonist A method comprising administering is provided. Compositions and dietary supplements comprising angiogenin are also provided. [Selection] Figure 2 |